An opioid made in the brain is crucial for remembering others
It would be inconvenient if we couldn’t remember the people we have or haven’t met before. Social recognition, the ability to differentiate familiar or novel individuals of the same species is part of a larger process of social memory that allows groups within a species to build and maintain stable networks or relationships, like what we know as friend groups or communities.
The hippocampus, known for its role in memory, is divided into subregions that contribute to different memory processes, and one called CA2 is particularly important for social memory. . Enkephalin, a neuropeptide that interacts with opioid receptors, is needed in CA2 to recognize new people.
Enkephalins belong to a class of opioids produced by the brain which are often associated with stress response and pain relief. The researchers found that in CA2, these compounds are released by specific type of neuron, boosting information transfer to the CA2, thus enabling our brains to form social memories.
Scientists studied the effects of enkephalin through a social memory test in mice. They introduced one mouse to a space with two others, and the subject mouse was allowed to interact with each mouse for fiver minutes. The subject mouse was removed, then returned half an hour later, this time with one of the mice from the last entry and one mouse it had not met before. The typical response for mice in this case is to pay attention to the new mouse for longer. The scientists observed that, while mice with regular enkephalin levels sniffed out the new mouse for a longer amount of time, mice without enkephalin spent the same amount of time between both mice, as if they had not previously encountered one of them.
A better understanding of social memory can help demystify related diseases. Schizophrenia, a condition in which social memory is impaired, is treated with drugs affecting opioid receptors, for example. The results of this study shed light on how these treatments work.
This story originally appeared on , an editorial partner site that publishes science stories by scientists. to get even more science sent straight to you.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
What’s in a diagnosis?
When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.
Peer through a window to the future of science
Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.
Glow-based assay sheds light on disease-causing mutations
University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.
How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent ɬÀï·¬ paper.
A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent ɬÀï·¬ paper.
How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.